Altimmune
Presence
Altimmune is a company listed under the stock ticker ALT (US).
Executives
View the org chart displaying its 23 main executives
Most searched biographies at Altimmune
- Vipin Garg, Director, President and Chief Executive Officer
- Mitchel Sayare, Executive Chairman of the Board
- Philip Hodges, Director
Create your alert
to follow the executive moves at Altimmune.
Pharmaceuticals
Altimmune has 1,868 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Altimmune
- Altimmune to Report Second Quarter 2022 Financial Results and Provide Business Update on August 11 – Altimmune
- Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming EASL International Liver Congress™ on June 25, 2022 – Altimmune
- Press Releases – Altimmune
- Press Releases – Altimmune
- Altimmune to Participate at Two Upcoming Investor Conferences – Altimmune
- Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming American Diabetes Association Scientific Sessions June 6, 2022 – Altimmune
- Altimmune to Present Pemvidutide Clinical Data at Upcoming Global NASH Congress May 27, 2022 – Altimmune
- Altimmune to Present at Upcoming Investor Conferences – Altimmune
- Altimmune Announces First Quarter 2022 Financial Results and Provides a Corporate Update – Altimmune
- Altimmune to Report First Quarter 2022 Financial Results and Provide Business Update on May 12 – Altimmune
- View more press releases Close
Social media about Altimmune
- Altimmune on Wikipedia, Google News & Yahoo Finance
- Altimmune on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Raymond Jordt 
